Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-05

Clinical Trial Update: Creatine as a New Therapeutic Strategy in Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating creatine as a treatment for Major Depressive Disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine (creatine)

Snippet

Sponsor: Herzog Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: TERMINATED